Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-01-08 @ 6:30 AM
Study NCT ID:
NCT03596060
Status:
UNKNOWN
Last Update Posted:
2021-09-28
First Post:
2018-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Regional vs General Anesthesia in Patients With Hip Fracture Under Treatment With Clopidogrel
Sponsor:
Larissa University Hospital
Organization:
Study Overview
Official Title:
Regional vs General Anesthesia in Patients With Hip Fracture Under Treatment With Clopidogrel
Status:
UNKNOWN
Status Verified Date:
2021-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study compares general to regional anesthesia concerning morbidity and mortality in patients older than or equal to 65 years old who receive clopidogrel and are to be submitted in hip fracture surgery. Half of participants will receive general anesthesia the first 48 hours and the other half will receive regional anesthesia after 5 days of the discontinuation of clopidogrel.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: